Cargando…
Otologic and vestibular symptoms in COVID‐19: A scoping review
BACKGROUND: Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. OBJECTIVE: The aim of this review was to describe the otologic and vestibular...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111077/ https://www.ncbi.nlm.nih.gov/pubmed/35599837 http://dx.doi.org/10.1002/wjo2.57 |
_version_ | 1784709233483186176 |
---|---|
author | Ong, Kimberly Mae C. Cruz, Teresa Luisa G. |
author_facet | Ong, Kimberly Mae C. Cruz, Teresa Luisa G. |
author_sort | Ong, Kimberly Mae C. |
collection | PubMed |
description | BACKGROUND: Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. OBJECTIVE: The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID‐19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms. SOURCES OF EVIDENCE: Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included. ELIGIBILITY CRITERIA: Studies included were those involving adult patients diagnosed with COVID‐19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes. RESULTS: The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID‐19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID‐19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non‐COVID‐19 cases, in addition to the management for COVID‐19. In certain cases, there may be a need for additional work‐up to rule out other causes. CONCLUSIONS: Otologic and vestibular symptoms were present in COVID‐19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID‐19 should be considered in any patient with a new‐onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms. |
format | Online Article Text |
id | pubmed-9111077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91110772022-05-17 Otologic and vestibular symptoms in COVID‐19: A scoping review Ong, Kimberly Mae C. Cruz, Teresa Luisa G. World J Otorhinolaryngol Head Neck Surg Review Article BACKGROUND: Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. OBJECTIVE: The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID‐19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms. SOURCES OF EVIDENCE: Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included. ELIGIBILITY CRITERIA: Studies included were those involving adult patients diagnosed with COVID‐19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes. RESULTS: The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID‐19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID‐19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non‐COVID‐19 cases, in addition to the management for COVID‐19. In certain cases, there may be a need for additional work‐up to rule out other causes. CONCLUSIONS: Otologic and vestibular symptoms were present in COVID‐19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID‐19 should be considered in any patient with a new‐onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms. John Wiley and Sons Inc. 2022-04-06 /pmc/articles/PMC9111077/ /pubmed/35599837 http://dx.doi.org/10.1002/wjo2.57 Text en © 2022 The Authors. World Journal of Otorhinolaryngology ‐ Head and Neck Surgery published by John Wiley & Sons Ltd on behalf of Chinese Medical Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Article Ong, Kimberly Mae C. Cruz, Teresa Luisa G. Otologic and vestibular symptoms in COVID‐19: A scoping review |
title | Otologic and vestibular symptoms in COVID‐19: A scoping review |
title_full | Otologic and vestibular symptoms in COVID‐19: A scoping review |
title_fullStr | Otologic and vestibular symptoms in COVID‐19: A scoping review |
title_full_unstemmed | Otologic and vestibular symptoms in COVID‐19: A scoping review |
title_short | Otologic and vestibular symptoms in COVID‐19: A scoping review |
title_sort | otologic and vestibular symptoms in covid‐19: a scoping review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111077/ https://www.ncbi.nlm.nih.gov/pubmed/35599837 http://dx.doi.org/10.1002/wjo2.57 |
work_keys_str_mv | AT ongkimberlymaec otologicandvestibularsymptomsincovid19ascopingreview AT cruzteresaluisag otologicandvestibularsymptomsincovid19ascopingreview |